Introduction Hydroxychloroquine (HCQ) is an antimalarial drug that received worldwide
news and media attention in the treatment of patients with coronavirus disease 2019 (COVID …

Based on a demonstrated in vitro effect on SARS-CoV-2 and its known safety profile, both
chloroquine and hydroxychloroquine (CQ/HCQ) are currently being used off label to treat …

In December 2019, the novel coronavirus disease pandemic (COVID-19) that began in
China had infected so far more than 109,217,366 million individuals worldwide and …

The recent COVID-19 pandemic highlights the need for rapid responses in developing
treatment strategies for new and emerging diseases. The option to repurpose drugs …

Abstract Introduction Hydroxychloroquine (HCQ)/Chloroquine (CQ) has been evaluated for
treatment and prophylaxis against SARS-CoV-2 infection in various studies with conflicting …

The current pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) calls urgently for effective therapies. Anti …

Introduction Over the last few months, coronavirus disease 2019 (COVID-19) pandemic
caused by the novel coronavirus SARS-CoV-2 has posed a serious threat to public health …

Abstract The coronavirus infection (COVID-19) has turned into a global catastrophe and
there is an intense search for effective drug therapy. Of all the potential therapies …

Abstract The rapidly spreading Coronavirus Disease (COVID-19) pandemic, caused by the
severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents an …

Abstract Hydroxychloroquine (HCQ), a 4-aminoquinoline, is used worldwide mainly for its
role in management of malaria and rheumatoid arthritis. In the present pandemic of …